JENNIFER LEBLANC: Open Payments
NPI 1033108238 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,992 in 91 payments from 19 companies in 2025. Trend: 2023 $2,508 · 2024 $1,724 · 2025 $1,992
Food & beverage: $1,992
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $372 |
| UCB, Inc. | 12 | $231 |
| Hill Dermaceuticals, Inc. | 1 | $228 |
| Regeneron Healthcare Solutions, Inc. | 10 | $221 |
| Galderma Laboratories, L.P. | 13 | $175 |
| Novartis Pharmaceuticals Corporation | 5 | $111 |
| LEO Pharma Inc. | 5 | $99 |
| Botanix SB Inc | 4 | $87 |
| PFIZER INC. | 3 | $72 |
| Incyte Corporation | 3 | $70 |
Products named: Bimzelx, Tolak, SKYRIZI, DUPIXENT, COSENTYX, BOTOX, AKLIEF, SOFDRA.
Industry payments across LA — which companies pay providers there.
